CRLCharles River LaboratoriesHealth Care
$301.79EarningsNov 4, 2026
1D—1W—1M—3M—1Y—
Market cap$14.6BCompany infoRevenue$4.0B52-wk range$147 – $311IndustryMedical - Diagnostics & ResearchWebsitecriver.comRelated
Yahoo
EDGAR
CNN
FinvizMarket Beat
Perform
n/a
1 Year
n/a1 Month
n/a1 Week
n/a1 Day
Rank Durability
Persist
n/a
1 Year
n/a6 Month
n/a3 Month
n/aTrend Hold
Business Beat
Profit
n/a
Composite
n/aRevenue
n/aMargin
n/aCash Flow
Money Flow
Pressure
n/a
60 Day
n/a30 Day
n/a5 Day
n/a2 Day
▲ +105.3% · 1YSPY
Weekly rank vs S&P 500 · 52wk
Not enough history to plot
ValuationHow the price is priced — vs cohort and vs its own past
MetricValueUnivSect5-yr range
P / E———
P / S3.7×3646
2
7
P / FCF39.5×1717
13
52
EV / EBITDA77.4×44
12
58
P / E (fwd)26.6×——
ProfitabilityMargins and returns on capital
MetricValueUnivSect5-yr range
Gross margin32.2%2721
32%
38%
Operating margin12.3%3841
3%
18%
Net margin-6.0%716
-6%
12%
ROE-7.6%818
-8%
18%
ROIC7.1%3840
2%
10%
Financial healthLeverage and liquidity
MetricValueUnivSect5-yr range
Debt / equity0.923726
0.6
1.2
Net debt / EBITDA11.0×32
Current ratio1.354926
Interest coverage4.6×4237
Per shareTTM, with year-over-year change
Revenue / share$82.48▼ −1%
EPS (diluted)$-4.85▼ −265%
FCF / share$7.64▼ −36%
Est. EPS growth (fwd)+13%